Hyperglycemia, Hypoglycemia Linked to Poor Outcomes in COVID-19
David C. Klonoff, M.D., from the Mills-Peninsula Medical Center in San Mateo, California, and colleagues analyzed pooled data from the Glytec national database for 1,544 patients with COVID-19 from 91 hospitals in 12 states. Patients were stratified according to achieved mean glucose category during days 2 to 3 in non-intensive care unit (ICU) patients or on day 2 in ICU patients. The authors examined the association between glucose category and hospital mortality.
The researchers found that 18.1 percent of patients died in the hospital. Among non-ICU patients, compared with blood glucose <7.77 mmol/L, severe hyperglycemia (>13.88 mmol/L) on days 2 to 3 was independently associated with high mortality (adjusted hazard ratio, 7.17). This association was not significant for admission glucose. In patients admitted directly to the ICU, increased mortality was seen in association with severe hyperglycemia on admission (adjusted hazard ratio, 3.14). This association was not significant on day 2. There was also an association seen for hypoglycemia and increased mortality (odds ratio, 2.2).
"We found that severe hyperglycemia early in the course of hospitalization in patients with COVID-19 admitted to a non-ICU setting was associated with a sevenfold increase in mortality risk," the authors write. "Our results suggest patients with COVID-19 should promptly receive treatment to improve glycemic control."
Several authors disclosed financial ties to Glytec.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 19 to 22, 2021. This roundup...
FRIDAY, Jan. 22, 2021 -- Two-thirds of Americans are concerned about going to medical appointments even for an emergency when COVID-19 rates are high in their area, according to...
FRIDAY, Jan. 22, 2021 -- An antibody drug that has emergency use authorization from the U.S. Food and Drug Administration for use in early-stage COVID-19 patients with symptoms...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.